As per our new research report “Global Protein Therapeutics Market Analysis”, the US mAbs market is the largest in the world with over 38% share of the global monoclonal antibodies market in 2009. Our study indicates that a large number of monoclonal antibodies are in different phases of clinical development for a variety of diseases in the US.
We have identified some critical factors acting as a catalyst for the industry’s current and future growth outlook. The report reveals that the utmost growth rate in the US monoclonal antibody market is possibly to be observed for mAbs utilized for the treatment of cancer, followed by inflammatory, and immunological diseases. Further, research and development in the country for expansion of usage of drugs for several indications will further enhance the growth of mAbs oncology market in the coming years.
Besides, we have done thorough research and prudent analysis of the global protein therapeutics market and identified some critical factors acting as a catalyst for the industry’s current and future growth outlook. The report reveals that increase in the health insurance industry will drive renewed interests of the investors in the therapeutics market at the global level.
The systematic and thorough research studies the global protein therapeutics market to give an insight into its various segments, including Monoclonal Antibodies, Erythropoietins, Insulin, Interferon, Human Growth Hormone, Blood Clotting Factor, Granulocyte Colony Stimulating Factor, and Follicle Stimulating Hormone.
“Global Protein Therapeutics Market Analysis” provides thorough research and rational analysis along with reliable statistics of the global protein therapeutics industry. The report also provides extensive information on the traditional markets as well as on the emerging technologies. Besides, an insight of trends prevailing in the regional protein therapeutics market segments across the globe has been covered in the report. Analysis and statistics regarding market size, growth, share, segmentation, and geographic distribution have been thoroughly studied in the report to present a comprehensive view of the global protein therapeutics market. The report has thoroughly examined current market trends; industrial developments, and competitive landscape to enable clients understand the market structure and its progress in coming years.
For more information visit: http://www.rncos.com/Report/IM557.htm |
